This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sinocelltech Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Desheng Kong: Innovator in Antibody Development
Introduction
Desheng Kong is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work has the potential to impact various medical treatments and improve patient outcomes.
Latest Patents
Desheng Kong holds a patent for a "Humanized anti-VEGF antibody Fab fragment." This innovative invention addresses critical needs in the treatment of diseases related to vascular endothelial growth factor (VEGF), showcasing his expertise in antibody engineering.
Career Highlights
Kong is currently associated with Sinocelltech Ltd., a company known for its advancements in biopharmaceuticals. His role at the company allows him to leverage his skills in research and development, contributing to the creation of novel therapeutic solutions.
Collaborations
Throughout his career, Desheng Kong has collaborated with notable colleagues, including Liangzhi Xie and Chunyun Sun. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new technologies.
Conclusion
Desheng Kong's contributions to the field of biotechnology, particularly through his patent on a humanized anti-VEGF antibody Fab fragment, highlight his role as an influential inventor. His work at Sinocelltech Ltd. and collaborations with esteemed colleagues further underscore his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile